上实城市开发(00563)公布，公司(作为借款人)于2026年2月11日与一家银行(作为贷款人)订立两份贷款协 议，内容有关两笔总额为人民币9亿元的定期贷款融通，为期36个月。该融通将用于偿还现有的银行借 款。 ...

格隆汇2月11日丨上实城市开发(00563.HK)公告，公司(作为借款人)于2026年2月11日与一家银行(作为贷 款人)("贷款人")订立两份贷款协议，内容有关两笔总额为人民币9亿元定期贷款融通，为期三十6个月。 该融通将用于偿还现有银行借款。 ...

智通财经APP讯，上实城市开发(00563)公布，公司(作为借款人)于2026年2月11日与一家银行(作为贷款 人)订立两份贷款协议，内容有关两笔总额为人民币9亿元的定期贷款融通，为期36个月。该融通将用于 偿还现有的银行借款。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於百慕達註冊成立之有限公司） （股份代號：563） 根據上市規則第13.18條作出的公告 – 1 – 本公司董事會（「董事會」）認為，通過該融通進行融資將繼續維持本公司相對較低之 綜合融資成本，並優化本公司之債務架構。 根據上市規則第13.21條之規定，只要上述責任繼續存在，本公司將會繼續在其後之 中期及年度報告中作出披露。 承董事會命 本公告由上海實業城市開發集團有限公司（「本公司」）根據香港聯合交易所有限公司 證券上市規則（「上市規則」）第13.18條作出。 本公司（作為借款人）於二零二六年二月十一日與一家銀行（作為貸款人）（「貸款人」） 訂立兩份貸款協議（「該等貸款協議」），內容有關兩筆總額為人民幣900,000,000元之 定期貸款融通，為期三十六個月（「該融通」）。該融通將用於償還現有之銀行借款。 該等貸款協議規定，在該融通存續期內，上海實業（集團）有限公司（「上實集團」）作 為本公司及上海 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 上海實業城市開發集團有限公司 (於百慕達註冊成立之有限公司) 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00563 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.04 HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.04 HKD | | 400,000,000 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 上海實業城市開發集團有限公司 (於百慕達註冊成立之有限公司) 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00563 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.04 HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.04 HKD | | 400,000,000 ...

Core Viewpoint - Shanghai Industrial Holdings (00363) announced that its direct controlling shareholder, Shanghai Industrial Group, has informed the board that an internal restructuring proposal is expected to be completed by December 29, 2025, with Jinzhong registered as the owner of all issued shares of Shanghai Industrial Group [1] Group 1 - The registration of ownership by Shanghai Industrial Group will not involve any change in voting rights, which are currently held by the Shanghai Municipal Government [1] - As of the announcement date, Jinzhong indirectly holds controlling interests in the company (approximately 63.16% of issued shares), Shanghai Industrial Urban Development Group Limited (approximately 70.44% of issued shares), and Shanghai Industrial Environment Holdings Limited (approximately 50.12% of issued shares) [1] - Both Shanghai Industrial Urban Development and Shanghai Industrial Environment are non-wholly owned subsidiaries of the company [1] Group 2 - The ultimate control of the company, Shanghai Industrial Urban Development, and Shanghai Industrial Environment remains with the Shanghai Municipal Government, as Shanghai Industrial Group, Shanghai Shangi, and Jinzhong are all beneficially wholly owned by the Shanghai Municipal Government at all significant times [1]

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00563 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.04 | HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.04 | HKD | | 400,000,000 | 本月底法定/註冊股本總額： HKD 400,000,000 ...

Core Viewpoint - The company has entered into a conditional equity transfer agreement to sell a 49% stake in Shanghai Shanshi Medical Beauty Hospital Co., Ltd. for a total consideration of RMB 73.598 million, which aligns with its strategy to optimize asset allocation and focus on core business development [1] Group 1: Transaction Details - The agreement involves Shanghai Huashi and Shanghai Lingfeng Medical, with Shanghai Lingfeng Medical agreeing to purchase the stake from Shanghai Huashi and the company's wholly-owned subsidiary, Shanghai Dajiankang Management [1] - Upon completion of the transaction, the company will no longer hold any equity in the target company, which will be fully owned by Shanghai Lingfeng Medical [1] Group 2: Strategic Implications - The sale allows the company to recover and reallocate capital, streamline its investment portfolio, and concentrate resources on its main business, thereby enhancing operational efficiency and capital discipline [1] - This transaction is part of the company's ongoing strategy to improve cash flow and support long-term sustainable growth [1]

Group 1 - The target company is owned by Shanghai Lingfeng Medical (51%), Shanghai Huashi (30%), and Shanghai Dasheng Management (19%), with the group holding a 19% indirect interest classified as an investment in an associate [1] - Following the completion of the transaction, the company will no longer hold any interest in the target company, which will be wholly owned by Shanghai Lingfeng Medical, and the target company will cease to be an associate of the company [1] - The group aims to recover and reallocate capital through the sale, streamline its investment portfolio, and focus resources on core business operations to enhance operational efficiency and capital discipline [1] Group 2 - Shanghai Dasheng Management, a wholly-owned subsidiary of the company, has entered into a conditional equity transfer agreement with Shanghai Huashi and Shanghai Lingfeng Medical to sell a combined 49% stake in the target company, Shanghai Shanshi Medical Beauty Hospital Co., Ltd., for a total consideration of RMB 73.598 million [2]